2023 Q4 Form 10-Q Financial Statement

#000147793223008368 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $182.3K $290.0K
YoY Change -27.47% 10.74%
Operating Profit -$287.5K
YoY Change 9.79%
Interest Expense $4.384M $950.0K
YoY Change 138.62% -2.39%
% of Operating Profit
Other Income/Expense, Net -$3.898M $1.116M
YoY Change -354.2% 48.03%
Pretax Income $303.8K $830.0K
YoY Change -90.26% 68.6%
Income Tax
% Of Pretax Income
Net Earnings $303.8K $828.8K
YoY Change -90.26% 68.37%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.05 $0.14
COMMON SHARES
Basic Shares Outstanding 591.9K shares 7.129M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $210.00 $0.00
YoY Change -99.95% -100.0%
Cash & Equivalents $212.00 $212.00
Short-Term Investments
Other Short-Term Assets $0.00 $0.00
YoY Change -100.0% -100.0%
Inventory
Prepaid Expenses $0.00 $19.29K
Receivables
Other Receivables
Total Short-Term Assets $212.00 $19.44K
YoY Change -99.97% -97.63%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $6.589M $6.500M
YoY Change -97.05% -97.06%
Other Assets
YoY Change
Total Long-Term Assets $6.589M $6.515M
YoY Change -97.05% -97.06%
TOTAL ASSETS
Total Short-Term Assets $212.00 $19.44K
Total Long-Term Assets $6.589M $6.515M
Total Assets $6.589M $6.534M
YoY Change -97.05% -97.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $241.1K $206.1K
YoY Change 741.26% 869.68%
Deferred Revenue
YoY Change
Short-Term Debt $216.5K $200.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $593.3K $430.2K
YoY Change 280.9% 263.51%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $552.0K $1.000M
YoY Change -93.99% -90.65%
Total Long-Term Liabilities $552.0K $1.000M
YoY Change -93.99% -90.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $593.3K $430.2K
Total Long-Term Liabilities $552.0K $1.000M
Total Liabilities $1.145M $1.394M
YoY Change -87.73% -87.11%
SHAREHOLDERS EQUITY
Retained Earnings -$1.670M -$1.900M
YoY Change -80.83% -80.99%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.145M -$1.375M
YoY Change
Total Liabilities & Shareholders Equity $6.589M $6.534M
YoY Change -97.05% -97.06%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $303.8K $828.8K
YoY Change -90.26% 68.37%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.060K $0.00
YoY Change -98.34% -100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -1.060K 0.000
Cash From Investing Activities
Cash From Financing Activities 0.000 0.000
Net Change In Cash -1.060K 0.000
YoY Change -98.34% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$1.060K $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001848861
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
7702242 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41145
dei Entity Registrant Name
EntityRegistrantName
HEALTHCARE AI ACQUISITION CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1585450
dei Entity Address Address Line1
EntityAddressAddressLine1
8 The Green
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste 15614
dei Entity Address City Or Town
EntityAddressCityOrTown
Dover
dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19810
dei City Area Code
CityAreaCode
917
dei Local Phone Number
LocalPhoneNumber
446-0469
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
591851 shares
CY2023Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
6514571 usd
CY2022Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
223048887 usd
CY2023Q3 us-gaap Assets
Assets
6534011 usd
CY2022Q4 us-gaap Assets
Assets
223672996 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
206095 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28655 usd
CY2023Q3 haia Promissory Note Related Party
PromissoryNoteRelatedParty
216449 usd
CY2022Q4 haia Promissory Note Related Party
PromissoryNoteRelatedParty
0 usd
CY2023Q3 haia Amount Due To Related Parties Current
AmountDueToRelatedPartiesCurrent
7670 usd
CY2022Q4 haia Amount Due To Related Parties Current
AmountDueToRelatedPartiesCurrent
127095 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
430214 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
155750 usd
CY2023Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
963871 usd
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1314370 usd
CY2023Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
317285 usd
CY2023Q3 haia Deferred Underwriting Commisions
DeferredUnderwritingCommisions
0 usd
CY2022Q4 haia Deferred Underwriting Commisions
DeferredUnderwritingCommisions
7546840 usd
CY2023Q3 us-gaap Liabilities
Liabilities
1394085 usd
CY2022Q4 us-gaap Liabilities
Liabilities
9334245 usd
CY2023Q3 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
6514571 usd
CY2022Q4 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
223048887 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Profit Loss
ProfitLoss
492290 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
524380 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1899564 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8710675 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1374645 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-8710136 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6534011 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
223672996 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
954754 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-954754 usd
CY2023Q3 haia Interest Income Loss Securities Taxable
InterestIncomeLossSecuritiesTaxable
163452 usd
CY2022Q3 haia Interest Income Loss Securities Taxable
InterestIncomeLossSecuritiesTaxable
-219062 usd
haia Interest Income Loss Securities Taxable
InterestIncomeLossSecuritiesTaxable
4660324 usd
haia Interest Income Loss Securities Taxable
InterestIncomeLossSecuritiesTaxable
9200588 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1275125 usd
CY2023Q3 haia Change In Fv Of Overallotment Option
ChangeInFvOfOverallotmentOption
0 usd
CY2022Q3 haia Change In Fv Of Overallotment Option
ChangeInFvOfOverallotmentOption
0 usd
haia Change In Fv Of Overallotment Option
ChangeInFvOfOverallotmentOption
0 usd
haia Change In Fv Of Overallotment Option
ChangeInFvOfOverallotmentOption
155881 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1116370 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
754163 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5010823 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10631594 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
828847 usd
us-gaap Profit Loss
ProfitLoss
4024595 usd
us-gaap Profit Loss
ProfitLoss
9676840 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-8710136 usd
CY2023Q1 haia Accretion Of Interest Earned On Trust Account To Common Stock Subject To Possible Redemption
AccretionOfInterestEarnedOnTrustAccountToCommonStockSubjectToPossibleRedemption
-2362839 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-225709 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-11298684 usd
CY2023Q2 haia Accretion Of Interest Earned On Trust Account To Common Stock Subject To Possible Redemption
AccretionOfInterestEarnedOnTrustAccountToCommonStockSubjectToPossibleRedemption
-2134033 usd
CY2023Q2 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
524380 usd
CY2023Q2 us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
7546840 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3421457 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1940040 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1374645 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-18393982 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-10691740 usd
CY2022Q2 haia Re Measurement Of Class A Ordinary Shares Subject To Possible Redemption
ReMeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption
-301900 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1482308 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-9511332 usd
CY2022Q3 haia Re Measurement Of Class A Ordinary Shares Subject To Possible Redemption
ReMeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption
-973225 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
492290 usd
us-gaap Profit Loss
ProfitLoss
4024595 usd
us-gaap Profit Loss
ProfitLoss
9676840 usd
haia Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
-4660324 usd
haia Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
-1275125 usd
haia Change In Warrant Liability
ChangeInWarrantLiability
-350499 usd
haia Change In Warrant Liability
ChangeInWarrantLiability
-9200588 usd
haia Change In Overallotment Liability
ChangeInOverallotmentLiability
0 usd
haia Change In Overallotment Liability
ChangeInOverallotmentLiability
-155881 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-203606 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-390540 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
177440 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1355859 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
174119 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
90000 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
30000 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
42000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-401063 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1788073 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-246766 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-246766 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-401063 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2034839 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
401275 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2500000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
212 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
465161 usd
us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
0 usd
us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
36 usd
haia Accretion Of Interest Earned On Shares To Cssr
AccretionOfInterestEarnedOnSharesToCssr
4760324 usd
haia Accretion Of Interest Earned On Shares To Cssr
AccretionOfInterestEarnedOnSharesToCssr
1275125 usd
us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
7546840 usd
us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
0 usd
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
177095 usd
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
0 usd
haia Deferred Offering Costs Assumed By Related Party Charge To Additiona Paid In Capital
DeferredOfferingCostsAssumedByRelatedPartyChargeToAdditionaPaidInCapital
347285 usd
haia Deferred Offering Costs Assumed By Related Party Charge To Additiona Paid In Capital
DeferredOfferingCostsAssumedByRelatedPartyChargeToAdditionaPaidInCapital
0 usd
haia Redemption Of Shares From Marketable Securities Held In Trust Account
RedemptionOfSharesFromMarketableSecuritiesHeldInTrustAccount
221294640 usd
haia Redemption Of Shares From Marketable Securities Held In Trust Account
RedemptionOfSharesFromMarketableSecuritiesHeldInTrustAccount
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
100000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023Q2 us-gaap Assets Held In Trust
AssetsHeldInTrust
50000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statement in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p>
us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC Topic 815, “Derivatives and Hedging—Contracts in Entity’s Own Equity” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. In accordance with ASC Topic 825 “Financial Instruments,” offering costs attributable to the issuance of the derivative warrant liabilities have been allocated based on their relative fair value of total proceeds and are recognized in the statement of operations as incurred.</p>
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
223048887 usd
haia Founder Shares
FounderShares
1437500 shares
haia Amount Of New Sponser Loaned
AmountOfNewSponserLoaned
116449 usd
haia Amount Interest Bearing And Unsecured Promissory Note
AmountInterestBearingAndUnsecuredPromissoryNote
1500000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001

Files In Submission

Name View Source Status
0001477932-23-008368-index-headers.html Edgar Link pending
0001477932-23-008368-index.html Edgar Link pending
0001477932-23-008368.txt Edgar Link pending
0001477932-23-008368-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
haia-20230930.xsd Edgar Link pending
haia_10q.htm Edgar Link pending
haia_ex311.htm Edgar Link pending
haia-20230930_cal.xml Edgar Link unprocessable
haia-20230930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
haia-20230930_lab.xml Edgar Link unprocessable
haia-20230930_pre.xml Edgar Link unprocessable
haia_10q_htm.xml Edgar Link completed
haia_ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending